[Temporary Announcement] Fukang Pharmaceutical: Announcement of the company’s application for a loan from Bank of China Co., Ltd. Dunhua Branch
Announcement number: 2026-006 Securities code: 831838 Securities abbreviation: Fukang Pharmaceutical Sponsored securities firm: Cathay Haitong
Jilin Fukang Pharmaceutical Co., Ltd.
To Bank of China Co., Ltd. Dunhua Branch
Announcement of loan application
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and that there are no false records, misleading statements or major omissions, and bear individual and joint legal liability for the authenticity, accuracy and completeness of the contents.
1. Basic information about applying for a loan from the bank
The company recently applied for a credit loan from Bank of China Co., Ltd. Dunhua Branch. The loan amount is RMB 5 million (lower case: 5 million yuan). The loan term is 1 year. The specific contract date shall be subject to the actual withdrawal date.
Purpose of borrowing: to purchase raw materials and supplement insufficient working capital.
2. Deliberation and voting
In accordance with the relevant provisions of the "National Small and Medium Enterprises Equities Exchange and Quotations Company Governance Rules" and the "Articles of Association", the 12th meeting of the fourth session of the Board of Directors held on January 12, 2026 reviewed and approved this proposal. This proposal does not require review by the shareholders' meeting.
3. The necessity of applying for a loan and its impact on the company
This application for a bank loan is a normal need for the company's business development and production operations. It is conducive to the company's sustainable and stable operations and will not harm the interests of the company and shareholders.
Announcement number: 2026-006
4. Documents for reference
Resolution of the 12th meeting of the 4th board of directors of Jilin Fukang Pharmaceutical Co., Ltd.
Jilin Fukang Pharmaceutical Co., Ltd.
Board of Directors January 12, 2026